checkAd

     435  0 Kommentare Research and Markets - Immunohistochemistry Market to Reach $2 Billion by 2021 - Key Vendors are Abcam Plc, Cell Signaling Technology & Perkinelmer

    DUBLIN, Dec 7, 2016 /PRNewswire/ --

    Research and Markets has announced the addition of the "Immunohistochemistry Market by Product, Application and End User - Global Forecast to 2021" report to their offering.

    The immunohistochemistry (IHC) market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period of 2016 to 2021.

    Factors such as the growing prevalence of cancer and rapidly increasing geriatric population across the globe are the primary driving the growth of this market. Other factors driving the IHC market growth include increasing healthcare spending and improving healthcare infrastructure resulting in an increasing number of hospitals and diagnostic laboratories. Several manufacturers in the immunohistochemistry market are relied majorly on launching the new products in order to achieve growth in the immunohistochemistry market. In addition, market players are focusing on acquiring local market players to expand their portfolios and enhance their distribution channels in emerging markets.

    North America is the largest market for immunohistochemistry, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia-Pacific possesses lucrative growth potential for the immunohistochemistry market during the forecast period. The economic growth of APAC countries, rising number of chronic diseases, rising standard of living, growing demand for quality medical care, increasing healthcare spending and government initiatives, and rising awareness on the use of immunohistochemistry tests are expected to drive market growth of the Asia-Pacific region during the forecast period.

    Companies Mentioned:

    • Abcam Plc
    • Agilent Technologies, Inc.
    • Bio SB
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology, Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Merck Millipore
    • Perkinelmer, Inc.
    • Thermo Fisher Scientific Inc.

    Key Topics Covered:

    1 Introduction

    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview 

    6 Industry Insights

    7 Global Immunohistochemistry Market, by Product

    8 Global Immunohistochemistry Market, by Application

    9 Global Immunohistochemistry Market, by End User

    10 Global Immunohistochemistry Market, by Region

    11 Competitive Landscape

    12 Company Profiles

    13 Appendix

    For more information about this report visit http://www.researchandmarkets.com/research/qmdzdl/immunohistochemist

    Media Contact:

    Research and Markets

    Laura Wood, Senior Manager

    press@researchandmarkets.com

    For E.S.T Office Hours Call +1-917-300-0470

    For U.S./CAN Toll Free Call +1-800-526-8630

    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907

    Fax (outside U.S.): +353-1-481-1716

     




    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Research and Markets - Immunohistochemistry Market to Reach $2 Billion by 2021 - Key Vendors are Abcam Plc, Cell Signaling Technology & Perkinelmer DUBLIN, Dec 7, 2016 /PRNewswire/ - Research and Markets has announced the addition of the "Immunohistochemistry Market by Product, Application and End User - Global Forecast to 2021" report to their offering. The immunohistochemistry (IHC) market …